Clinical Trials Browser

Phase 2 × ribociclib × Gastrointestinal × Clear all

NCT02524119 2021-02-01

LEE001

Phase 2 Terminated

5 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02420691 2020-10-30

Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Phase 2 Completed

21 enrolled 14 charts

Gastrointestinal

Non functioning pancreatic endocrine tumor, Thymus Neoplasms